Add to ORKGPatients with some types of cardiovascular disease are prescribed anticoagulation therapy with Warfa...
BACKGROUND: Increasing indications for oral anticoagulation has led to pressure on general practices...
Background: Managing warfarin therapy can be challenging and a multidisciplinary approach to achieve...
Objective Pharmacogenomic-guided dosing has the potential to improve patient outcomes but its imple...
Warfarin therapy is known as a complex process because of the variation in the patients\u27 response...
Warfarin is the most widely prescribed anticoagulant for prevention and treatment of thromboembolic ...
新型抗凝药物的研发是近年来心血管疾病治疗中最活跃的部分,但是华法林作为最古老的口服抗凝药物仍然是需要长期抗凝治疗患者的最常用药物,例如静脉血栓栓塞性疾病、心房颤动血栓栓塞的预防、瓣膜病和瓣膜置换术后,...
This report presents the development of an algorithm for the prediction of the effects of warfarin, ...
目的:分析和总结华法林与抗肿瘤药物和相关辅助药物的相互作用,为临床安全用药提供参考.方法:采用回顾性分析的方法,通过医院信息管理系统调取2006年1月-2015年12月我院住院患者使用华法林的医嘱,提...
The first aim of this study was to develop a prothrombin time international normalized ratio (PT INR...
BACKGROUND: There is an increasing move towards clinical decision making that engages the patient, w...
Background: Warfarin is the most common oral anticoagulant. This drug is used for the prevention and...
Introduction: Warfarin is FDA approved for a variety of indications Recommended INR goal ranges ca...
ABSTRACTBackground: Pharmacy-managed warfarin dosing has been established at Burnaby Hospital, in Bu...
Computerised decision support software (CDSS) for anticoagulation management has become established ...
Patients with some types of cardiovascular disease are prescribed anticoagulation therapy with Warfa...
BACKGROUND: Increasing indications for oral anticoagulation has led to pressure on general practices...
Background: Managing warfarin therapy can be challenging and a multidisciplinary approach to achieve...
Objective Pharmacogenomic-guided dosing has the potential to improve patient outcomes but its imple...
Warfarin therapy is known as a complex process because of the variation in the patients\u27 response...
Warfarin is the most widely prescribed anticoagulant for prevention and treatment of thromboembolic ...
新型抗凝药物的研发是近年来心血管疾病治疗中最活跃的部分,但是华法林作为最古老的口服抗凝药物仍然是需要长期抗凝治疗患者的最常用药物,例如静脉血栓栓塞性疾病、心房颤动血栓栓塞的预防、瓣膜病和瓣膜置换术后,...
This report presents the development of an algorithm for the prediction of the effects of warfarin, ...
目的:分析和总结华法林与抗肿瘤药物和相关辅助药物的相互作用,为临床安全用药提供参考.方法:采用回顾性分析的方法,通过医院信息管理系统调取2006年1月-2015年12月我院住院患者使用华法林的医嘱,提...
The first aim of this study was to develop a prothrombin time international normalized ratio (PT INR...
BACKGROUND: There is an increasing move towards clinical decision making that engages the patient, w...
Background: Warfarin is the most common oral anticoagulant. This drug is used for the prevention and...
Introduction: Warfarin is FDA approved for a variety of indications Recommended INR goal ranges ca...
ABSTRACTBackground: Pharmacy-managed warfarin dosing has been established at Burnaby Hospital, in Bu...
Computerised decision support software (CDSS) for anticoagulation management has become established ...
Patients with some types of cardiovascular disease are prescribed anticoagulation therapy with Warfa...
BACKGROUND: Increasing indications for oral anticoagulation has led to pressure on general practices...
Background: Managing warfarin therapy can be challenging and a multidisciplinary approach to achieve...